Compare Stock Earnings
Side-by-side earnings, revenue, and financial performance comparison
Biomarin Pharmaceutical Inc
$58.51
+1.77%
Mkt Cap: $11.3B
Avg ER Move: ±2%
Earnings Track Record (6Q)
3 Beats
3 Misses
Whisper Beat: 50%
Last 4 Quarters
Q4'26
$-0.08
✅ BEAT +27.3%
Q3'26
$0.90
✅ BEAT +13.9%
📈 +3.8%
Q3'26
$0.90
✅ BEAT +13.9%
📈 +1.2%
Q2'26
$0.76
❌ MISS -16.9%
📈 +2.6%
Latest Revenue
$874.6M
+17.0% YoY
Gross: 66.3%
Op: 9.1%
Net: -5.3%